Molecular exploration of combinational therapy of orlistat with metformin prevents the COVID-19 consequences in obese diabetic patients

Eur Rev Med Pharmacol Sci. 2021 Jan;25(2):580-582. doi: 10.26355/eurrev_202101_24614.
No abstract available

Publication types

  • Letter
  • Review

MeSH terms

  • Anti-Obesity Agents / administration & dosage
  • COVID-19 / epidemiology
  • COVID-19 / prevention & control*
  • Diabetes Mellitus / drug therapy*
  • Diabetes Mellitus / epidemiology
  • Drug Therapy, Combination
  • Humans
  • Hypoglycemic Agents / administration & dosage
  • Metformin / administration & dosage*
  • Obesity / drug therapy*
  • Obesity / epidemiology
  • Orlistat / administration & dosage*

Substances

  • Anti-Obesity Agents
  • Hypoglycemic Agents
  • Metformin
  • Orlistat